Annovis Bio (ANVS) announced the appointment of Matthew Peterson, Ph.D., as Senior Clinical Scientist. Dr. Peterson will be responsible for medical, ethical, and scientific quality and rigor in the initiation, conduct, reporting, and successful completion of Annovis’ clinical trials.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANVS:
- Apple downgraded, Tesla upgraded: Wall Street’s top analyst calls
- Annovis Bio upgraded to Buy at Maxim following buntanetap update
- Annovis Bio upgraded to Buy from Hold at Maxim
- Annovis Bio says FDA clears company to launch Phase 3 Alzheimer’s studies
- Annovis Bio Files Patents for Neurodegenerative Combination Therapies